Overview

Food Oral Immunotherapy for Peanut Allergy

Status:
Enrolling by invitation
Trial end date:
2026-06-01
Target enrollment:
0
Participant gender:
All
Summary
This is an open label observational single center study of clinical food oral immunotherapy outcomes with biomarker samples and participant and/or caregiver-completed questionnaires in participants between 6 months and 65 years of age with IgE-mediated peanut allergy undergoing food oral immunotherapy.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Immunologic Factors
Criteria
Inclusion Criteria:

- Individuals between 6 months and 65 years of age with a diagnosis of immunoglobulin E
(IgE)-mediated peanut allergy and their caregivers; a diagnosis of IgE-mediated peanut
allergy is defined by: (1) documented history of peanut allergy or determined to be
allergic by oral food challenge; (2) evidence of peanut-specific IgE by either:
positive skin prick test to peanut allergen (reaction wheal at least 3 mm larger than
saline control) or serum peanut-specific IgE > 0.34 kilo-unit/liter (kU/L) or
international unit/milliliter (IU/mL) at screening visit

- Referral by Massachusetts General Hospital (MGH) allergist for food oral immunotherapy

- Willing to sign informed consent or whose caregiver is willing to sign the informed
consent (age appropriate)

- Willing to sign the assent form, if age appropriate

Exclusion Criteria:

- History of severe or life-threatening episode of anaphylaxis or anaphylactic shock
within 60 days of screening

- Severe or poorly controlled asthma

- Diagnosis of other severe or complicating medical problems, including autoimmune or
chronic immune inflammatory conditions or gastrointestinal inflammatory conditions,
such as inflammatory bowel diseases and eosinophilic gastrointestinal disorders

- Current use of beta blocker medication(s)

- Inability to cooperate with and/or perform oral food challenge procedures

- Females who are pregnant, planning to become pregnant, or breastfeeding

- Investigator determination of safety concern for any reason